Navigation Links
Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products
Date:6/8/2011

ctive portfolio of products under development, filed, or intended for filing, as ANDA's with the US FDA and the Chinese SFDA. Amerigen's focus is orally delivered products that are challenging to develop, require specialized technologies or high containment to manufacture, and present complex regulatory and intellectual property obstacles to bring to market. All Amerigen's products are developed and manufactured by the company or its partners around the world to meet the highest quality standards, including the US FDA.

About AustarPharma

AustarPharma is a technology based pharmaceutical company based in Edison NJ, USA. The core competencies of the company are advanced drug delivery technologies. The key established platform technologies include several controlled-release technologies, such as osmotic pump extended-release technology, and many solubilization technologies used to enhance bioavailability and reduce bio-variability of water-insoluble drugs.  AustarPharma has taken advantages of these platform technologies to collaborate with multiple companies in the US and overseas to develop high technology barrier products. With the acquisition of Abbott's cGMP commercial manufacturing and testing facility at Edison, NJ in 2009, AustarPharma is now able to develop a drug product from very beginning in laboratories all the way to commercialization in the US and worldwide markets.


'/>"/>
SOURCE Amerigen Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ... (OFT) approval condition to the announced tender offer for all of ... As a result of the waiver, the transaction is no longer ... offer on January 24, 2014 following the currently scheduled expiration time, ...
(Date:1/15/2014)... , January 15, 2014 BreedIT Corp ... exclusive worldwide distributor of highly sophisticated agro-breeding solutions for ... 7, 2014, the Company,s board of directors appointed chemistry ... as its new member of the board. ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... July 12 MedPro Imaging, a leading supplier ... been chosen by the Chicago Bears Football Club, Inc. to ... other health issues for the team during the upcoming 2010 ... Mobile Imaging Services division which offers mobile ultrasound services throughout ...
... July 12 Endo Pharmaceuticals (Nasdaq: ENDP ) today ... offer by its wholly owned subsidiary, HT Acquisition Corp., for all ... HTRN).  American Stock Transfer & Trust Company, the depositary for the ... , New York City time, on July 9, ...
Cached Medicine Technology:MedPro Imaging to Supply Mobile Ultrasound Diagnostics to Chicago Bears Players 2MedPro Imaging to Supply Mobile Ultrasound Diagnostics to Chicago Bears Players 3Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 2Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 3Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 4
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary ... Paul Kenis in the Institute of Genomic Biology ... Illinois Urbana-Champaign describe their recent work on subcellular ... of cell functions including energy metabolism, signaling, and ... regulating normal cellular behavior, redox status has been ...
(Date:4/17/2014)... MD, was recently invited to submit a review ... Microbiology , one of the world,s foremost scientific ... specialist, and chair of the Department of Pediatrics ... analyzed the epidemiology and microbiology of co-infections during ... as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... many as 10 million older Americans suffer from depression, ... , However, new research a project that followed ... six years found that Internet use among the ... than 30 percent. , "That,s a very strong effect," ... telecommunication, information studies and media who led the project. ...
(Date:4/17/2014)... Boston University School of Medicine (BUSM) have discovered ... in an experimental model. The findings, reported in ... Abuse , may lead to more effective treatments ... one of the leading causes of illness and ... economic impact by limiting the productivity of workers ...
(Date:4/17/2014)... An international research team led by Cesar A. Arias, ... Center at Houston (UTHealth) has identified a new superbug ... The report appeared in the April 17 issue of ... The new superbug is part of a class of ... or MRSA, which is a major cause of hospital ...
Breaking Medicine News(10 mins):Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:New MRSA superbug emerges in Brazil 2
... Presbyterian Medical Center, high rates of chronic hepatitis B infection ... the New York City area, and most of them do ... considered the standard of care for all persons newly identified ... but one infant was protected from infection in this study, ...
... whose mothers are successfully treated for depression show progressive and ... their moms discontinue treatment, new UT Southwestern Medical Center-led research ... their kids improved and the greater the degree of ... is depressed and don,t even go through the process of ...
... Reporter , MONDAY, May 9 (HealthDay News) -- Among Medicare ... new study finds. But at the same time, a ... may not always be getting the follow-up colonoscopies they need ... which blood is detected in the stool. Both reports ...
... Steven Reinberg HealthDay Reporter , MONDAY, May 9 ... with a lethal nervous system disease known as amyotrophic lateral ... however, that this does not mean people with long ring ... are at higher risk for it. "We have not ...
... By Maureen Salamon HealthDay Reporter , MONDAY, ... concerns, new Korean research suggests that long-term use of ... is linked to an increased risk of fractures. ... 1997 and 2011 found that proton pump inhibitors (PPIs), ...
... , MONDAY, May 9 (HealthDay News) -- People with ... of suffering another attack or dying after even a ... painkillers, including Advil, Motrin or Voltarin, a large ... of almost 84,000 heart attack survivors and found that ...
Cached Medicine News:Health News:Routine antenatal screening for hepatitis B in an urban NYC population 2Health News:Successful depression treatment of mothers has long-term effects on offspring 2Health News:Successful depression treatment of mothers has long-term effects on offspring 3Health News:Study Questions Overuse of Colonoscopy in Medicare Patients 2Health News:Study Questions Overuse of Colonoscopy in Medicare Patients 3Health News:Study Questions Overuse of Colonoscopy in Medicare Patients 4Health News:Ring Finger Length Linked to ALS, Study Suggests 2Health News:Ring Finger Length Linked to ALS, Study Suggests 3Health News:Popular Heartburn Meds May Boost Fracture Risk 2Health News:Popular Heartburn Meds May Boost Fracture Risk 3Health News:After Heart Attack, Certain Painkillers May Raise Risk for Recurrence 2Health News:After Heart Attack, Certain Painkillers May Raise Risk for Recurrence 3
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Medicine Products: